However, in vitro analyses on prostate cancer showed that CD26 has a suppressor function on tumor progression by blocking the basic fibroblast growth factor signaling pathway (24) or suppressing the chemotactic migration of tumor cells (25). The gene discussed is FGF2; the disease is neoplasm.